Emergence of oxacillinase-181 carbapenemase-producing diarrheagenic


Journal

Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 22 4 2021
medline: 3 11 2021
entrez: 21 4 2021
Statut: ppublish

Résumé

The emergence and spread of carbapenemase-producing bacteria are serious threats to public health. We characterized two OXA-181-producing

Identifiants

pubmed: 33879019
doi: 10.1080/22221751.2021.1920342
pmc: PMC8110189
doi:

Substances chimiques

Anti-Bacterial Agents 0
Escherichia coli Proteins 0
beta-Lactamases EC 3.5.2.6
oxacillinase EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

865-873

Références

J Antimicrob Chemother. 2010 Mar;65(3):490-5
pubmed: 20071363
PLoS One. 2018 Dec 21;13(12):e0209623
pubmed: 30576382
Emerg Infect Dis. 2019 Apr;25(4):739-747
pubmed: 30882333
Commun Biol. 2019 Aug 29;2:322
pubmed: 31482141
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
pubmed: 28594827
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
Am J Trop Med Hyg. 2009 Aug;81(2):296-301
pubmed: 19635887
Emerg Infect Dis. 2020 Sep;26(9):2235-2238
pubmed: 32818427
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Clin Microbiol Rev. 2019 Nov 13;33(1):
pubmed: 31722889
F1000Res. 2018 Feb 15;7:193
pubmed: 29511533
Int J Food Microbiol. 2008 Sep 30;127(1-2):172-5
pubmed: 18675485
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
Antimicrob Agents Chemother. 2011 Oct;55(10):4896-9
pubmed: 21768505
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Infect Drug Resist. 2020 Apr 06;13:995-998
pubmed: 32308440
Antimicrob Agents Chemother. 2015 Aug;59(8):5022-5
pubmed: 26014927
Nucleic Acids Res. 2014 Jan;42(Database issue):D206-14
pubmed: 24293654
mSphere. 2018 Jul 18;3(4):
pubmed: 30021879
J Antimicrob Chemother. 2018 Mar 1;73(3):626-633
pubmed: 29272439
Open Forum Infect Dis. 2020 Mar 28;7(4):ofaa109
pubmed: 32373647
Front Microbiol. 2020 Jan 21;10:3095
pubmed: 32038543
Infect Drug Resist. 2019 Jun 21;12:1729-1742
pubmed: 31417290
BMC Infect Dis. 2018 Feb 1;18(1):63
pubmed: 29390982
J Antimicrob Chemother. 2017 May 1;72(5):1340-1349
pubmed: 28199647
Iran J Microbiol. 2013 Mar;5(1):42-7
pubmed: 23466523
Antimicrob Agents Chemother. 2015;59(6):3556-62
pubmed: 25870058
Jpn J Infect Dis. 2021 Mar 24;74(2):115-121
pubmed: 32863350
Antimicrob Agents Chemother. 2016 Apr 22;60(5):3240-2
pubmed: 26883710
BMC Infect Dis. 2019 Mar 21;19(1):275
pubmed: 30898105
PLoS One. 2009 Sep 03;4(9):e6531
pubmed: 19727445
Antimicrob Agents Chemother. 2013 Apr;57(4):1965-7
pubmed: 23357767
Int J Antimicrob Agents. 2013 Mar;41(3):294-6
pubmed: 23313398
J Glob Antimicrob Resist. 2020 Sep;22:568-570
pubmed: 32603904
Bioinformatics. 2011 Apr 1;27(7):1009-10
pubmed: 21278367
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349

Auteurs

Isaac Prah (I)

Department of Molecular Microbiology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Department of Molecular Virology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

Alafate Ayibieke (A)

Department of Molecular Microbiology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

Samiratu Mahazu (S)

Department of Molecular Microbiology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Department of Environmental Parasitology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

Chihiro Tani Sassa (CT)

Department of Clinical Laboratory, Tokyo Medical and Dental University Medical Hospital, Tokyo, Japan.

Takaya Hayashi (T)

Department of Molecular Virology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

Shoji Yamaoka (S)

Department of Molecular Virology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

Toshihiko Suzuki (T)

Department of Bacterial Pathogenesis, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

Shiroh Iwanaga (S)

Department of Environmental Parasitology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

Anthony Ablordey (A)

Bacteriology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.

Ryoichi Saito (R)

Department of Molecular Microbiology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH